Baader Bank Aktiengesellschaft’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,000	Closed	-$4.53K	–	523
2023 Q1	$4.53K	Buy	+14,000	New	+$5.99K	﹤0.01%	362

Other funds holding SIOX

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Baader Bank Aktiengesellschaft's SIOX Position: Q2 2023 in Review

Baader Bank Aktiengesellschaft sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2023, closing a stake of 14,000 shares — an estimated $4.53K sold.

Baader Bank Aktiengesellschaft first reported a position in SIOX in Q1 2023 and held it in 1 quarter. The position peaked at $4.53K in Q1 2023. 1 fund tracked by Wall St. Rank holds SIOX as of Q2 2023.

Baader Bank Aktiengesellschaft reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 14,000 Sio Gene Therapies Inc. Common Stock shares in Q2 2023, an estimated $4.53K.
Baader Bank Aktiengesellschaft first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Sio Gene Therapies Inc. Common Stock position peaked at $4.53K in Q1 2023.
1 fund tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2023, filed 11 Aug 2023.